Concepedia

Wes E. Kim

WE

Statistics

Publications

5

Citations

220

H-Index

5

Active since

2002

Affiliations

University of Maryland, Baltimore(Current)

A&G Pharmaceutical (United States)

Wes E. Kim is an author at University of Maryland, Baltimore specializing in molecular oncology, medicine, and oncology.

Publications per year

2002–2015

5

Publications

5

PC cell-derived growth factor (granulin precursor) expression and action in human multiple myeloma.

Wengang Wang, Jun Hayashi, Wes E. Kim et al. · PubMed · 2003 · 67 citations

Medicine, Cell Biology, Oncology +16

Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma

Ginette Serrero, Binbin Yue, Olga B. Ioffe et al. · Breast Cancer Research · 2012 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +14

PC Cell–Derived Growth Factor Stimulates Proliferation and Confers Trastuzumab Resistance to Her-2-Overexpressing Breast Cancer Cells

Wes E. Kim, Ginette Serrero · Clinical Cancer Research · 2006 · 44 citations

Medicine, Oncology, Pharmacology +12

N-Arylalkylpiperidines as High-Affinity Sigma-1 and Sigma-2 Receptor Ligands: Phenylpropylamines as Potential Leads for Selective Sigma-2 Agents

Dean Y. Maeda, Wanda Williams, Wes E. Kim et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer Cells

Wes E. Kim, Binbin Yue, Ginette Serrero · Breast Cancer Basic and Clinical Research · 2015 · 13 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

1–5 of 5